BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

28 related articles for article (PubMed ID: 17559126)

  • 1. Association of XRCC1 Arg399Gln and Arg194Trp polymorphisms with susceptibility to multiple autoimmune diseases: a meta-analysis.
    Peng M; Zhou X; Ding X; Wei L; Zhao Y; Zhu T; Shi X; Qin D
    Rheumatol Int; 2017 Mar; 37(3):435-444. PubMed ID: 27812739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genome-wide association study identifies common genetic variants associated with salivary gland carcinoma and its subtypes.
    Xu L; Tang H; Chen DW; El-Naggar AK; Wei P; Sturgis EM
    Cancer; 2015 Jul; 121(14):2367-74. PubMed ID: 25823930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between the XRCC1 Arg194Trp polymorphism and risk of cancer: evidence from 201 case-control studies.
    Feng YZ; Liu YL; He XF; Wei W; Shen XL; Xie DL
    Tumour Biol; 2014 Nov; 35(11):10677-97. PubMed ID: 25064613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The XRCC1 Arg194Trp and Arg280His polymorphisms in head and neck cancer susceptibility: a meta-analysis.
    Zhou X; Gu L; Zeng Y; Wei L; Ying M; Wang N; Su C; Wang Y; Liu C
    Tumour Biol; 2014 Nov; 35(11):10665-76. PubMed ID: 25062722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of X-ray repair cross-complementing group 1 Arg194Trp, Arg399Gln and Arg280His polymorphisms with head and neck cancer susceptibility: a meta-analysis.
    Wu W; Liu L; Yin Z; Guan P; Li X; Zhou B
    PLoS One; 2014; 9(1):e86798. PubMed ID: 24497981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA repair gene XRCC1 polymorphisms and head and neck cancer risk: an updated meta-analysis including 16344 subjects.
    Lou Y; Peng WJ; Cao DS; Xie J; Li HH; Jiang ZX
    PLoS One; 2013; 8(9):e74059. PubMed ID: 24086310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. XRCC1 Arg399Gln polymorphism is not associated with oral cancer risk: evidence from a meta-analysis.
    Liu B; Shen T
    Tumour Biol; 2014 Jan; 35(1):507-12. PubMed ID: 24052436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. XRCC1 Arg194Trp polymorphism is associated with oral cancer risk: evidence from a meta-analysis.
    Zhang Y; Wang Y; Wu J; Li LJ
    Tumour Biol; 2013 Aug; 34(4):2321-7. PubMed ID: 23681796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. XRCC1 polymorphism and lung cancer risk.
    Schneider J; Classen V; Helmig S
    Expert Rev Mol Diagn; 2008 Nov; 8(6):761-80. PubMed ID: 18999926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. XRCC1 polymorphisms and cancer risk: a meta-analysis of 38 case-control studies.
    Hu Z; Ma H; Chen F; Wei Q; Shen H
    Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1810-8. PubMed ID: 16030121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. X-ray repair cross-complementing group 1 (XRCC1) single-nucleotide polymorphisms and the risk of salivary gland carcinomas.
    Ho T; Li G; Lu J; Zhao C; Wei Q; Sturgis EM
    Cancer; 2007 Jul; 110(2):318-25. PubMed ID: 17559126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-nucleotide polymorphisms of DNA repair genes OGG1 and XRCC1: association with gallbladder cancer in North Indian population.
    Srivastava A; Srivastava K; Pandey SN; Choudhuri G; Mittal B
    Ann Surg Oncol; 2009 Jun; 16(6):1695-703. PubMed ID: 19266243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A population-based case-control study of the Arg399Gln polymorphism in DNA repair gene XRCC1 and risk of breast cancer.
    Shu XO; Cai Q; Gao YT; Wen W; Jin F; Zheng W
    Cancer Epidemiol Biomarkers Prev; 2003 Dec; 12(12):1462-7. PubMed ID: 14693738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A population-based study of the Arg399Gln polymorphism in X-ray repair cross- complementing group 1 (XRCC1) and risk of pancreatic adenocarcinoma.
    Duell EJ; Holly EA; Bracci PM; Wiencke JK; Kelsey KT
    Cancer Res; 2002 Aug; 62(16):4630-6. PubMed ID: 12183419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective study of XRCC1 (X-ray cross-complementing group 1) polymorphisms and breast cancer risk.
    Patel AV; Calle EE; Pavluck AL; Feigelson HS; Thun MJ; Rodriguez C
    Breast Cancer Res; 2005; 7(6):R1168-73. PubMed ID: 16457697
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.